Produkty 327048-86-2

CAS 327048-86-2 występuje w naszej ofercie pod nazwami: 4-Androstene-3,17-Dione (2,3,4-13C3), 4-ANDROSTENE-3,17-DIONE-2,3,4-13C3 SOLUT. Oferty producentów: TRC, Sigma-Aldrich. Dostępne opakowania: 10mg, 1ML.

4-Androstene-3,17-Dione (2,3,4-13C3)
TRC
  • opakowanie: 10mg
  • Warianty: 1
Zobacz produkt
4-ANDROSTENE-3,17-DIONE-2,3,4-13C3 SOLUT
Sigma-Aldrich
  • opakowanie: 1ML
  • Warianty: 1
od 1891,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione (CAS 327048-86-2) to związek chemiczny o wzorze sumarycznym C19H26O2 i masie molowej 289.39 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione. InChIKey: AEMFNILZOJDQLW-FZIFMXJCSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H26O2
Masa molowa289.39 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
InChIKeyAEMFNILZOJDQLW-FZIFMXJCSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=[13CH][13C](=O)[13CH2]C[C@]34C

Dane obliczone przez PubChem (NCBI)

Synonimy: 4-Androstene-3,17-dione-13C3, 4-Androstene-3,17-Dione (2,3,4-13C3), orb2308685, Androstene-3,17-dione-2,3,4-13C3, Androstenedione-2,3,4-13C3 Solution in Methanol, 10ug/mL, Androstenedione-2,3,4-13C3 Solution in Acetonitrile, 10ug/mL
Powiązane formy tego związku
(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O2
(8R,9S,10R,13R,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O2
(8R,9S,10R,13S,14S)-13-methyl-10-(trideuteriomethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O2
(8R,9S,10R,13S,14S)-2,2,4,6,6,16,16-heptadeuterio-10,13-dimethyl-1,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,17-dione C19H26O2
Izomery (ten sam wzór sumaryczny)
(10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2
(8R,9S,13S,14S,17S)-2,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol C19H26O2
(8S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2
(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C19H26O2
2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol C19H26O2
(8R,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C19H26O2
(8R,9S,10R,13S,14S)-13-ethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione C19H26O2
(3S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one C19H26O2